Company Background
Fresenius Kabi employs around 40,000 people worldwide. In 2021 the company reported sales of more than € 7 billion. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as medical devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. Within transfusion technology, Fresenius Kabi offers products used in the collection and processing of blood and cell components, as well as in transfusion medicine and cell therapies. The company is committed to putting essential medicines and technologies in the hands of people who help critically and chronically ill patients and finding the best answers to the challenges they face.
Company Description
Fresenius Kabi Contract Manufacturing provides partners access to the expertise of more than 20 manufacturing sites and worldwide, specializing in the fill/finish of sterile solutions and emulsions in Non-PVC and PVC IV-bags, bottles, vials, ampoules and pre-filled syringes in both glass and plastic.
Production licenses by US-FDA, European Health Authorities and other regulatory bodies cover aseptically filled and terminally sterilized products. Fresenius Kabi Contract Manufacturing collaborates with some of the largest pharmaceutical companies worldwide but is also the partner of choice for many biotech and start-up companies.
Services and Capabilities
Fresenius Kabi Contract Manufacturing provides its customers with seamless support throughout the entire life-cycle of their sterile products. From development support to scale-up, re-design, and flexibility of manufacturing processes, we are there during each stage of your product launch through to commercial manufacturing. Our project management team and in-house analytical services are key offerings for our customers.
Manufacturing Technologies
- Aseptic processing, terminal sterilization
- Processing of solutions and disperse systems such as emulsions and liposomes, suspensions, and PGLA microparticles
- Handling of high-active APIs
- Development and Clinical Trial Supply
- State of the art packaging and labeling
Facilities
Manufacturing Locations are located in:
- Austria
- Brazil
- Chile
- China
- France
- Germany
- Indonesia
- Italy
- Mexico
- Norway
- Portugal
- South Africa
- Sweden
- USA
- Vietnam